EPIC BIO

Serial Number 97280933
602

Registration Progress

Application Filed
Feb 23, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

EPIC BIO

Basic Information

Serial Number
97280933
Filing Date
February 23, 2022
Abandonment Date
September 18, 2023
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 5, 2023
Classes
042

Rights Holder

Epicrispr Biotechnologies, Inc.

03
Address
Suite 100
7000 Shoreline Court
South San Francisco, CA 94080

Ownership History

Epicrispr Biotechnologies, Inc.

Original Applicant
03
South San Francisco, CA

Legal Representation

Attorney
Anne H. Peck

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description
Dec 5, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 5, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 5, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 12, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 12, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 15, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 15, 2023 GNFR O FINAL REFUSAL E-MAILED
Mar 15, 2023 CNFR R FINAL REFUSAL WRITTEN
Feb 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 14, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2022 GNRT F NON-FINAL ACTION E-MAILED
Dec 15, 2022 CNRT R NON-FINAL ACTION WRITTEN
Dec 7, 2022 DOCK D ASSIGNED TO EXAMINER
Mar 2, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 1, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Research and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto

Additional Information

Design Mark
The mark consists of the terms epic and bio in lower case characters. The "dot" on the letter "i" in the term epic is below that letter rather than above; both that "dot" and the one on the letter "i" in the term bio are depicted as arrows. The two terms are separated by curved diagonal chain of dots which are faint at the top of the chain and intensify in appearance along the length of the chain.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042